CD8A and COVID-19: Together, these data demonstrate that both CD4+ and CD8+ SARS-CoV-2-specific memory T cells are maintained and are able to produce effector cytokines after restimulation three months post-symptom onset in mildly symptomatic COVID-19 individuals.